What to do with an intraductal papilary mucinous pancreatic neoplasm? Our experience

Cir Esp. 2016 Oct;94(8):467-72. doi: 10.1016/j.ciresp.2016.05.012. Epub 2016 Jul 25.
[Article in English, Spanish]

Abstract

Introduction: Cystic pancreatic neoplasms are a heterogeneous group of pathology, and intraductal papillary mucinous neoplasia is becoming more common. The aim of this study is to review our series of cystic pancreatic neoplasms that underwent surgery and to evaluate the similarities with Fukuoka recommendations.

Methods: Retrospective review of our experience analyzing clinical and radiological data, indication for surgery and pathology study of 11 patients operated on in our centre from july 2011 to july 2015, aiming to evaluate the degree of agreement with the current consensus.

Results: In our series the majority of cases (7/11) had symptoms at diagnosis. Preoperative diagnosis was achieved in 10 patients using radiology and/or endoscopy. Indications for surgery were the presence of symptoms, radiological data suspicious of malignancy, and secondary branch neoplasia over 30mm. Pathological findings were malignancy in 6/11 cases (2 invasive neoplasia, 4 high grade dysplasia), moderate dysplasia in 2/11, low-grade dysplasia in 2/11 and no dysplasia in one patient.

Conclusions: Surgical indication of intraductal mucinous pancreatic neoplasms depends on the associated symptoms, size, location, risk and suspicion of malignancy.

Keywords: Factores pronósticos; Intraductal papillary mucinous neoplasm; Management; Manejo; Neoplasia mucinosa papilar intraductal; Neoplasia pancreática; Neoplasia quística pancreática; Pancreatic cystic neoplasia; Pancreatic neoplasms; Prognostic factors.

MeSH terms

  • Adenocarcinoma, Mucinous / surgery*
  • Aged
  • Carcinoma, Pancreatic Ductal / surgery*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Pancreatic Neoplasms / surgery*
  • Retrospective Studies